Joel Schneider
Dr. Schneider received his B.Sc. in chemistry from the University of Akron in 1991, followed by a Ph.D. (1995) in chemistry from Texas A&M University. After which, he became a George W. Raiziss Postdoctoral Fellow at the University of Pennsylvania (1996-1999) studying protein design. He started his independent career at the University of Delaware (1999) in the Department of Chemistry and Biochemistry as a Francis Alison assistant professor. He remained at the University for ten years, with positions in Chemistry and Biochemistry, the Center for Translational Cancer Research, as well as Materials Science and Engineering, becoming full professor in 2010. After which, he moved to the National Cancer Institute, Center for Cancer Research to become Chief of Chemical Biology, where he currently resides. Dr. Schneider is also Editor in Chief of Biopolymers Peptide Science-Wiley, the Journal of the American Peptide Society. The Schneider group designs and characterizes novel materials for use in tissue regenerative therapy, parenteral delivery of therapeutics, delivery of cells, and antibacterial therapy. The group is particularly interested in peptide and protein-based hydrogel materials formed by self-assembly mechanisms. Their work spans molecular conception, materials synthesis, nano- and bulk mechanical materials characterization, cell-material interactions, biocompatibility, and assessment of performance efficacy. Thier basic research establishes how material composition and structure influences material function, and lays the foundation to ultimately translate materials to the clinic.
Abstracts this author is presenting: